News from venaxis, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jun 22, 2015, 16:05 ET

Venaxis Business Update

 Venaxis®, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on advancing commercialization of its CE Marked...

Apr 06, 2015, 09:00 ET

Venaxis to Provide Business Update

Venaxis®, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on advancing commercialization of its CE Marked APPY1™...

Feb 12, 2015, 09:00 ET

Venaxis Business Update

 Venaxis®, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on advancing commercialization of its CE Marked...

Jan 29, 2015, 06:25 ET

Venaxis Receives FDA "Not Substantially Equivalent" Response on APPY1 510(k) Submission

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on advancing commercialization of its CE Marked APPY1™...

Jan 06, 2015, 16:10 ET

Venaxis, Inc. to Present at Biotech Showcase™ 2015

 Venaxis®, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked...

Dec 03, 2014, 16:35 ET

Venaxis Files Response to FDA's Request for Additional Information

 Venaxis®, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE...

Nov 13, 2014, 16:15 ET

Venaxis to Present at Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE...

Oct 27, 2014, 16:30 ET
APPY1 Test Patient Disposition Flowchart

Venaxis' APPY1 Trial Results Presented by Dr. David S. Huckins, M.D., at ACEP14

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE...

Oct 14, 2014, 16:05 ET

Venaxis Announces APPY1 Test Clinical Trial Results to be Presented at ACEP14

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE...

Aug 28, 2014, 09:15 ET

Venaxis to Present at September Investor Conferences

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE...

Aug 11, 2014, 08:10 ET

Venaxis Announces Regulatory and Market Development Progress

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked...

Aug 07, 2014, 16:15 ET

Venaxis to Provide Business Update, including FDA Submission Update

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked...

Aug 05, 2014, 16:15 ET

Venaxis to Present at Canaccord Genuity 34th Annual Growth Conference

 Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1™...

Jul 16, 2014, 09:15 ET

Venaxis Reports on Recent FDA Submission Activities

CASTLE ROCK, Colo., July 16, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA...

Jul 01, 2014, 16:10 ET

Venaxis to Present at ICV Company Outreach Summit

Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1™...

May 21, 2014, 16:15 ET

Venaxis to Participate in 11th Annual Craig-Hallum Institutional Investor Conference

Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1™...

Apr 08, 2014, 16:01 ET

Venaxis, Inc. Closes Public Offering of Common Shares

 Venaxis, Inc. (NASDAQ:APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked...

Apr 03, 2014, 09:00 ET

Venaxis, Inc. Prices $20.0 Million Public Offering of Common Shares

 Venaxis, Inc. (NASDAQ: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked...

Apr 02, 2014, 16:01 ET

Venaxis, Inc. Announces Proposed Public Offering of Common Shares

Venaxis, Inc. (NASDAQ: APPY), an in vitro diagnostic company focused on obtaining FDA clearance for and commercializing its CE Marked APPY1™...

Mar 31, 2014, 07:30 ET

Venaxis Files for FDA Clearance of APPY1 Test

CASTLE ROCK, Colo., March 31, 2014 /PRNewswire/-- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA...